Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Current Taxes (2016 - 2026)

Bio-Techne has reported Current Taxes over the past 16 years, most recently at $2.5 million for Q4 2025.

  • For Q4 2025, Current Taxes fell 21.17% year-over-year to $2.5 million; the TTM value through Dec 2025 reached $2.5 million, down 21.17%, while the annual FY2025 figure was $10.8 million, 190.61% up from the prior year.
  • Current Taxes for Q4 2025 was $2.5 million at Bio-Techne, down from $2.8 million in the prior quarter.
  • Over five years, Current Taxes peaked at $25.3 million in Q4 2022 and troughed at $2.5 million in Q4 2025.
  • A 5-year average of $9.0 million and a median of $6.6 million in 2021 define the central range for Current Taxes.
  • Biggest five-year swings in Current Taxes: surged 290.49% in 2021 and later crashed 73.71% in 2023.
  • Year by year, Current Taxes stood at $14.3 million in 2021, then skyrocketed by 76.96% to $25.3 million in 2022, then crashed by 73.71% to $6.6 million in 2023, then tumbled by 52.74% to $3.1 million in 2024, then dropped by 21.17% to $2.5 million in 2025.
  • Business Quant data shows Current Taxes for TECH at $2.5 million in Q4 2025, $2.8 million in Q3 2025, and $10.8 million in Q2 2025.